Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1R. [electronic resource]
Producer: 20170629Description: 1545-56 p. digitalISSN:- 1538-8514
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression
- Gene Knockdown Techniques
- Humans
- Indazoles -- pharmacology
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinase Inhibitors -- pharmacology
- Receptor, IGF Type 1 -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Sulfonamides -- pharmacology
- Triple Negative Breast Neoplasms -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.